SEC Form 4 · accession 0001305773-17-000041
Conformis Inc · CFMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philipp Lang
Director
Period of report
Feb 14, 2017
Accepted (ET)
Feb 16, 2017 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305773
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Feb 14, 2017 | S | 106,774 | $8.60 | D | 728,147 | I | See footnote. |
| Common StockF4,F3 | Feb 15, 2017 | S | 31,194 | $8.60 | D | 696,953 | I | See footnote. |
| Common Stock | Feb 16, 2017 | M | 44,140 | $4.32 | A | 558,759 | D | |
| Common Stock | Feb 16, 2017 | M | 19,011 | $5.26 | A | 577,770 | D | |
| Common Stock | Feb 16, 2017 | M | 18,181 | $5.50 | A | 595,951 | D | |
| Common StockF5 | holding | — | — | — | 12,498 | I | See footnote. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $4.32 | Feb 16, 2017 | M | 44,140 | D | — | Sep 30, 2020 | Common Stock | 44,140 | 0 | D |
| Stock Option (right to buy)F6 | $5.26 | Feb 16, 2017 | M | 19,011 | D | — | Sep 27, 2021 | Common Stock | 19,011 | 120,118 | D |
| Stock Option (right to buy)F6 | $5.50 | Feb 16, 2017 | M | 18,181 | D | — | Mar 27, 2022 | Common Stock | 18,181 | 33,716 | D |
Explanation of responses
- F1This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
- F2The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $8.6000-$8.6025, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3The shares are held directly by the NP Irrevocable Trust udt dated 12/28/12. The Reporting Person's immediate family members are beneficiaries of the NP Irrevocable Trust udt dated 12/28/12, and the Reporting Person disclaims beneficial ownership of all shares except to the extent of his pecuniary interest therein.
- F4The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $8.6000-$8.6100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5The shares are held directly by the Reporting Person's children.
- F6This option is fully vested.